dpollo@hotmail.com | |
  • Inicio
  • Artículos PubMed
  • Inversion 16 (inv(16)) acute myeloid leukemia (AML) following treatment with radiation, capecitabine, and temozolomide in a patient with metastatic neuroendocrine tumor (NET).

Inversion 16 (inv(16)) acute myeloid leukemia (AML) following treatment with radiation, capecitabine, and temozolomide in a patient with metastatic neuroendocrine tumor (NET).

Escrito por orixwp el . Posteado en Artículos PubMed

Related Articles Inversion 16 (inv(16)) acute myeloid leukemia (AML) following treatment with radiation, capecitabine, and temozolomide in a patient with metastatic neuroendocrine tumor (NET). Leuk Lymphoma. 2019 11;60(11):2793-2797 Authors: Joseph R, McRee AJ, Mathews S, Zeidner JF PMID: 31119961 [PubMed – indexed for MEDLINE]
Origen: Inversion 16 (inv(16)) acute myeloid leukemia (AML) following treatment with radiation, capecitabine, and temozolomide in a patient with metastatic neuroendocrine tumor (NET). – PubMed

Etiquetas:

orixwp

This information box about the author only appears if the author has biographical information. Otherwise there is not author box shown. Follow YOOtheme on Twitter or read the blog.


Blog

Síguenos en:

Colaboradores

Search